MAALOX PLUS

200/175/25 MG/5ml Oral Suspension

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/109/001

Marketing Status

22 Mar 2016 - 15 Feb 201715 Feb 2017 - Present
Temporarily Not MarketedMarketed
« Back

Latest Changes to Medicine Info & SPC


Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.